Trial Profile
a triple-blind, randomized, active-controlled, parallel-group, multicenter study to evaluate and compare the efficacy and tolerability of alendronate sodium [alendronic acid] with calcium supplementation in the treatment of osteoporosis in postmenopausal women
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Calcium carbonate
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms COMPLETED
- Sponsors Merck Sharp & Dohme; Organon
- 25 Nov 2006 New trial record.